These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 18263783)
1. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Ekström Smedby K; Vajdic CM; Falster M; Engels EA; Martínez-Maza O; Turner J; Hjalgrim H; Vineis P; Seniori Costantini A; Bracci PM; Holly EA; Willett E; Spinelli JJ; La Vecchia C; Zheng T; Becker N; De Sanjosé S; Chiu BC; Dal Maso L; Cocco P; Maynadié M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan JR; Breen EC; Birmann B; Grulich AE; Cozen W Blood; 2008 Apr; 111(8):4029-38. PubMed ID: 18263783 [TBL] [Abstract][Full Text] [Related]
2. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371 [TBL] [Abstract][Full Text] [Related]
3. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Fallah M; Liu X; Ji J; Försti A; Sundquist K; Hemminki K Ann Oncol; 2014 Oct; 25(10):2025-2030. PubMed ID: 25081899 [TBL] [Abstract][Full Text] [Related]
4. Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Mellemkjaer L; Pfeiffer RM; Engels EA; Gridley G; Wheeler W; Hemminki K; Olsen JH; Dreyer L; Linet MS; Goldin LR; Landgren O Arthritis Rheum; 2008 Mar; 58(3):657-66. PubMed ID: 18311836 [TBL] [Abstract][Full Text] [Related]
5. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Morton LM; Slager SL; Cerhan JR; Wang SS; Vajdic CM; Skibola CF; Bracci PM; de Sanjosé S; Smedby KE; Chiu BC; Zhang Y; Mbulaiteye SM; Monnereau A; Turner JJ; Clavel J; Adami HO; Chang ET; Glimelius B; Hjalgrim H; Melbye M; Crosignani P; di Lollo S; Miligi L; Nanni O; Ramazzotti V; Rodella S; Costantini AS; Stagnaro E; Tumino R; Vindigni C; Vineis P; Becker N; Benavente Y; Boffetta P; Brennan P; Cocco P; Foretova L; Maynadié M; Nieters A; Staines A; Colt JS; Cozen W; Davis S; de Roos AJ; Hartge P; Rothman N; Severson RK; Holly EA; Call TG; Feldman AL; Habermann TM; Liebow M; Blair A; Cantor KP; Kane EV; Lightfoot T; Roman E; Smith A; Brooks-Wilson A; Connors JM; Gascoyne RD; Spinelli JJ; Armstrong BK; Kricker A; Holford TR; Lan Q; Zheng T; Orsi L; Dal Maso L; Franceschi S; La Vecchia C; Negri E; Serraino D; Bernstein L; Levine A; Friedberg JW; Kelly JL; Berndt SI; Birmann BM; Clarke CA; Flowers CR; Foran JM; Kadin ME; Paltiel O; Weisenburger DD; Linet MS; Sampson JN J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):130-44. PubMed ID: 25174034 [TBL] [Abstract][Full Text] [Related]
6. Autoimmune diseases and risk of non-Hodgkin lymphoma: A Mendelian randomisation study. Shi X; Wallach JD; Ma X; Rogne T medRxiv; 2024 Jan; ():. PubMed ID: 38343812 [TBL] [Abstract][Full Text] [Related]
7. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Anderson LA; Gadalla S; Morton LM; Landgren O; Pfeiffer R; Warren JL; Berndt SI; Ricker W; Parsons R; Engels EA Int J Cancer; 2009 Jul; 125(2):398-405. PubMed ID: 19365835 [TBL] [Abstract][Full Text] [Related]
8. Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium. 't Mannetje A; De Roos AJ; Boffetta P; Vermeulen R; Benke G; Fritschi L; Brennan P; Foretova L; Maynadié M; Becker N; Nieters A; Staines A; Campagna M; Chiu B; Clavel J; de Sanjose S; Hartge P; Holly EA; Bracci P; Linet MS; Monnereau A; Orsi L; Purdue MP; Rothman N; Lan Q; Kane E; Costantini AS; Miligi L; Spinelli JJ; Zheng T; Cocco P; Kricker A Environ Health Perspect; 2016 Apr; 124(4):396-405. PubMed ID: 26340796 [TBL] [Abstract][Full Text] [Related]
9. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Engels EA; Cerhan JR; Linet MS; Cozen W; Colt JS; Davis S; Gridley G; Severson RK; Hartge P Am J Epidemiol; 2005 Dec; 162(12):1153-61. PubMed ID: 16251389 [TBL] [Abstract][Full Text] [Related]
10. The association of immune disease and malignant lymphoma. Miller DG Ann Intern Med; 1967 Mar; 66(3):507-21. PubMed ID: 4959981 [No Abstract] [Full Text] [Related]
11. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336 [TBL] [Abstract][Full Text] [Related]
12. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. Morton LM; Sampson JN; Cerhan JR; Turner JJ; Vajdic CM; Wang SS; Smedby KE; de Sanjosé S; Monnereau A; Benavente Y; Bracci PM; Chiu BC; Skibola CF; Zhang Y; Mbulaiteye SM; Spriggs M; Robinson D; Norman AD; Kane EV; Spinelli JJ; Kelly JL; La Vecchia C; Dal Maso L; Maynadié M; Kadin ME; Cocco P; Costantini AS; Clarke CA; Roman E; Miligi L; Colt JS; Berndt SI; Mannetje A; de Roos AJ; Kricker A; Nieters A; Franceschi S; Melbye M; Boffetta P; Clavel J; Linet MS; Weisenburger DD; Slager SL J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):1-14. PubMed ID: 25174022 [TBL] [Abstract][Full Text] [Related]
13. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Vajdic CM; Falster MO; de Sanjose S; Martínez-Maza O; Becker N; Bracci PM; Melbye M; Smedby KE; Engels EA; Turner J; Vineis P; Costantini AS; Holly EA; Kane E; Spinelli JJ; La Vecchia C; Zheng T; Chiu BC; Dal Maso L; Cocco P; Maynadié M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan JR; Breen EC; Birmann B; Cozen W; Grulich AE Cancer Res; 2009 Aug; 69(16):6482-9. PubMed ID: 19654312 [TBL] [Abstract][Full Text] [Related]
15. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Zintzaras E; Voulgarelis M; Moutsopoulos HM Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762 [TBL] [Abstract][Full Text] [Related]
16. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study. Löfström B; Backlin C; Sundström C; Ekbom A; Lundberg IE Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247 [TBL] [Abstract][Full Text] [Related]
18. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Baimpa E; Dahabreh IJ; Voulgarelis M; Moutsopoulos HM Medicine (Baltimore); 2009 Sep; 88(5):284-293. PubMed ID: 19745687 [TBL] [Abstract][Full Text] [Related]
19. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study. Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661 [TBL] [Abstract][Full Text] [Related]
20. Malignant lymphomas in patients with autoimmune diseases: a report of 6 cases and a review of the Japanese literature. Sugai S; Tachibana J; Sawada M; Shimizu S; Hirose Y; Takiguchi T; Konda S Jpn J Med; 1987 Aug; 26(3):339-47. PubMed ID: 3320428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]